Coronavirus (COVID-19) Replace: FDA Authorizes First Oral Antiviral for Therapy of COVID-19
[ad_1] For Quick Launch: December 22, 2021 Español As we speak, the U.S. Meals and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the therapy of mild-to-moderate coronavirus illness (COVID-19) in adults and pediatric sufferers (12 years of age and older weighing… Read More »